Abstract
Severe COVID-19 is often associated with detrimental elevations in blood glucose, but the mechanisms are poorly understood. In this issue of Nature Metabolism, Wan et al. identify GP73 as a SARS-CoV-2-induced secreted factor that enhances hepatic glucose production and is necessary for SARS-CoV-2-associated glucose abnormalities.